Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4 Other solid neoplasm 2 Breast 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Other hematologic neoplasm 1 Gynecologic 1

Conditions

Ovarian Carcinosarcoma 1

Interventions

Paclitaxel 79 Carboplatin 66 pembrolizumab 61 Bevacizumab 56 Cisplatin 48 Specimen Handling 29 Drug Therapy 26 Blood Specimen Collection 24 Cyclophosphamide 20 olaparib 19 Taxes 17 Magnetic Resonance Spectroscopy 16 Letrozole 16 Gemcitabine 16 Biopsy 16 liposomal doxorubicin 15 niraparib 14 fludarabine 14 Brachytherapy 14 Radiotherapy 13 abemaciclib 12 Topotecan 11 Nivolumab 11 Injections 11 Doxorubicin 11 lenvatinib 10 Fluorouracil 10 Surveys and Questionnaires 9 Standard of Care 9 Oxaliplatin 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Antineoplastic Agents × Gynecologic × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡